Patent · US Expired

Recombinant agents affecting thrombosis

US5795863A · kind A · utility

17Cited by
7References
16Claims
0Family size

Assignee

Inventor

Key dates

Filing dateJun 7, 1995
Grant dateAug 18, 1998
Priority date
Expiry dateJun 7, 2015

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Analogs of Factor Xa (Factor Xai) which are inactive as proteases in the prothrombinase reaction are useful in treatment of diseases characterized by thrombosis. These antithrombotic agents can be conveniently prepared using recombinant techniques.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.